No Data
No Data
Dynavax (NASDAQ:DVAX) Offers Potentially Robust Growth at a Rich Valuation
Chief Accounting Officer Justin Burgess Sells Shares of Dynavax Technologies Corp (DVAX)
11 Best Small Cap Pharma Stocks to Invest In
Dynavax Technologies(DVAX.US) Officer Sells US$262.32K in Common Stocks
$Dynavax Technologies(DVAX.US)$ Officer Burgess Justin sold 20,526 shares of Common Stocks on Mar 1, 2024 at an average price of $12.78 for a total value of $262.32K.Source: Announcement What is state
Dynavax to Present at TD Cowen's 44th Annual Health Care Conference
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines,...
The Dynavax Technologies Corporation (NASDAQ:DVAX) Annual Results Are Out And Analysts Have Published New Forecasts
It's been a good week for Dynavax Technologies Corporation (NASDAQ:DVAX) shareholders, because the company has just released its latest yearly results, and the shares gained 2.7% to US$12.75. R
No Data